Venous Thromboembolism clinical trials at University of California Health
4 in progress, 2 open to eligible people
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
open to eligible people ages 18 years and up
This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using…
at UC Irvine
United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot
open to eligible people ages 3 months to 12 years
The main research question of this study is to obtain further safety and effectiveness data on Pradaxa Pellets in children aged 3 months to less than 12 years in routine clinical practice setting.
at UCSD
LMWH Vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology
Sorry, accepting new patients by invitation only
Aspirin and low molecular weight heparin (LMWH) are both commonly employed pharmacologic methods of venous thromboembolism (VTE) prophylaxis after orthopaedic surgery. Data comparing these two methods of VTE prophylaxis in patients undergoing…
at UCLA
Women's Health Initiative Strong and Healthy Study
Sorry, in progress, not accepting new patients
The WHISH trial applies state-of-the science behavioral principles and currently available technologies to deliver a physical activity intervention without face-to-face contact to ~25,000 older U.S. women expected to consent. It includes the…
at UCSD
Our lead scientists for Venous Thromboembolism research studies include Andrea Z LaCroix, PhD.
Last updated: